We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
+12.3%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$51B
AUM Growth
+$15.4B
Cap. Flow
+$11.4B
Cap. Flow %
22.45%
Top 10 Hldgs %
32.55%
Holding
2,383
New
382
Increased
1,739
Reduced
215
Closed
45

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$973M
2
MSFT icon
Microsoft
MSFT
+$944M
3
META icon
Meta Platforms (Facebook)
META
+$686M
4
AMZN icon
Amazon
AMZN
+$561M
5
NVDA icon
NVIDIA
NVDA
+$341M

Top Sells

Rank Stock Value
1
LEG icon
Leggett & Platt
LEG
+$127M
2
PBCT
People's United Financial Inc
PBCT
+$25.8M
3
ALB icon
Albemarle
ALB
+$25.2M
4
CDW icon
CDW
CDW
+$25.2M
5
FDS icon
Factset
FDS
+$23.1M

Sector Composition

Rank Sector Weight
1 Technology 33%
2 Consumer Discretionary 13.39%
3 Communication Services 11.47%
4 Healthcare 9.06%
5 Consumer Staples 8.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMPE
2326
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$24K ﹤0.01%
142
+59
+71% +$22K
UAVS icon
2327
AgEagle Aerial Systems
UAVS
$43M
$23K ﹤0.01%
+15
New +$36.3K
ARDX icon
2328
Ardelyx
ARDX
$1.26B
$22K ﹤0.01%
21,108
-12,247
-37% -$14.5K
AVTX icon
2329
Avalo Therapeutics
AVTX
$957M
$22K ﹤0.01%
+5
New +$30K
OBSV
2330
DELISTED
ObsEva SA Ordinary Shares
OBSV
$22K ﹤0.01%
+10,976
New +$26.6K
TRVN
2331
DELISTED
Trevena, Inc.
TRVN
$20K ﹤0.01%
57
+23
+68% +$12.7K
OPTN
2332
DELISTED
OptiNose
OPTN
$19K ﹤0.01%
+772
New +$25.8K
HOFV
2333
DELISTED
Hall of Fame Resort & Entertainment Co
HOFV
$18K ﹤0.01%
+553
New +$26.1K
LVO icon
2334
LiveOne
LVO
$72.8M
$17K ﹤0.01%
+1,289
New +$28.2K
EMWP
2335
DELISTED
Eros Media World PLC
EMWP
$17K ﹤0.01%
3,470
+1,434
+70% +$16.4K
TLMD
2336
DELISTED
SOC Telemed, Inc. Class A Common Stock
TLMD
$17K ﹤0.01%
+13,269
New +$26.6K
MBII
2337
DELISTED
Marrone Bio Innovations, Inc.
MBII
$15K ﹤0.01%
22,119
+9,280
+72% +$7.51K
KALA icon
2338
KALA BIO
KALA
$13.9M
$12K ﹤0.01%
4
-4
-50% -$18.6K
AUTL
2339
Autolus Therapeutics
AUTL
$373M
-12,192
Closed -$80K
AVDL
2340
DELISTED
Avadel Pharmaceuticals
AVDL
-12,477
Closed -$122K
CHKP icon
2341
Check Point Software Technologies
CHKP
$14.1B
-137,796
Closed -$15.6M
IGMS
2342
DELISTED
IGM Biosciences
IGMS
-6,510
Closed -$428K
MNOV icon
2343
MediciNova
MNOV
$66M
-10,461
Closed -$40K
NKTX icon
2344
Nkarta
NKTX
$184M
-8,838
Closed -$246K
OVID icon
2345
Ovid Therapeutics
OVID
$431M
-14,511
Closed -$49K
QNCX icon
2346
Quince Therapeutics
QNCX
$18.4M
-45
Closed -$816K
QURE icon
2347
uniQure
QURE
$2.73B
-10,770
Closed -$345K
RPTX
2348
DELISTED
Repare Therapeutics
RPTX
-7,929
Closed -$208K
TCOM icon
2349
Trip.com Group
TCOM
$27.8B
-547,770
Closed -$16.8M
UBX
2350
DELISTED
Unity Biotechnology
UBX
-1,177
Closed -$35K

Similar funds

ProShare Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, ProShare Advisors held 2,383 positions worth $51B, up 43% from $35.6B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

ProShare Advisors deployed $11.4B of net new capital in Q4 2021, opening 382 new positions and adding to 1,739 existing holdings. Its largest new stake was Lucid Motors: 272,628 shares worth $104M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 27% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was Leggett & Platt, an estimated $127M trimmed.

  • ProShare Advisors's largest Q4 2021 buy was Lucid Motors: 272,628 shares worth $104M.
  • ProShare Advisors added most to Apple in Q4 2021, an estimated $973M increase.
  • ProShare Advisors's biggest Q4 2021 reduction was Leggett & Platt, cutting an estimated $127M.
  • ProShare Advisors fully exited Stamps.com, Inc. in Q4 2021, selling an estimated $20.9M.
  • ProShare Advisors's ten largest holdings make up 33% of its $51B portfolio in Q4 2021.
  • ProShare Advisors opened 382 new positions and closed 45 in Q4 2021.
  • ProShare Advisors's portfolio value rose 43% quarter-over-quarter to $51B.

Based on ProShare Advisors's 13F filing for Q4 2021, filed 8 Feb 2022.